ReviewInvestigative ophthalmology & visual science2025
IMI-Myopia Genetics Report.
Review in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Comments on Diversified segmental defocus optimization lenses with and without atropine for myopia prevention: a randomized clinical trial.Annals of translational medicine · 2026Article
- Beyond Screen Time: A Measurement Framework for Behavioral Exposures in Childhood Myopia.Life (Basel, Switzerland) · 2026Review
- Dual-Hit Myopia Mechanism Unveiled by Multi-Omics: Opn1mw Deficiency Primed the Retina for Exaggerated Response to Environmental Defocus.Investigative ophthalmology & visual science · 2026Article
- A Shared Genetic Basis Underlying Myopia-Exotropia Comorbidity.Investigative ophthalmology & visual science · 2026Article
- Myopia as a Global Public Health Challenge a Narrative Review.Life (Basel, Switzerland) · 2026Review
- Neuro-ophthalmic review on pediatric myopia: Advancing from refraction to a brain-centric model of axial growth.World journal of clinical pediatrics · 2026Review
- From Genetic Diagnosis to Therapeutic Implementation in Retinal Diseases: Translational Advances and Persistent Bottlenecks.Biomedicines · 2026Review
- Genetic Architecture of Myopia and Its Implications for Risk Stratification and Prognosis.Diagnostics (Basel, Switzerland) · 2026Review
- Associations between mechanical stress and epigenetic modifications in outer retinal layer remodeling in high myopia.Frontiers in medicine · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The genetic landscape of myopia has advanced considerably since the previous International Myopia Institute genetics reports. This white paper provides an updated overview of current findings on myopia genetics and identifies priorities for future research. Methods: We performed a comprehensive literature review covering genome-wide association studies (GWASs), rare variant analyses, functional genomics, and multiomics approaches. Specific focus areas included common and high myopia, monogenic syndromes, and gene-environment interactions. Results: Over 1000 common variants have now been associated with refractive error and myopia, implicating pathways in retinal signaling, extracellular matrix remodeling, and neurodevelopment. Whole-exome and whole-genome sequencing studies have uncovered rare variants in new candidate genes for high and syndromic myopia. Polygenic risk scores show improved predictive power when combined with environmental and demographic factors. A growing number of studies have explored gene-environment interactions, genetic pleiotropy, and causal inference using Mendelian randomization. These analyses support a role for educational attainment, screen time, physical activity, and metabolic or inflammatory biomarkers in refractive error development. Conclusions: While a substantial portion of myopia heritability remains unexplained, future efforts should prioritize integrative approaches combining genetic, functional, and multiomics data across diverse populations. This will be essential for advancing personalized risk prediction, our understanding of gene-environment interplay, and identifying individuals most likely to benefit from targeted prevention or treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.